A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Feb, 7 2026
Mar, 18 2026
Feb, 1 2026
Dec, 26 2025
Dec, 10 2025